Please Wait.....
Report
Healthcare Analytical Testing Services Market Size by Type (Biomarker Testing, Stability Testing, Raw Material Testing, Batch-release Testing, Cleaning Validation), End User (Pharmaceutical Companies, Medical Device Companies) & Region - Global Forecast to 2029
Market Report I 2024-04-10 I 393 Pages I MarketsandMarkets
The Healthcare analytical testing services Market is projected to reach USD 12.6 billion by 2029 from USD 7.4 billion in 2024, at a CAGR of 11.2% during the forecast period. The growth of the healthcare analytical testing services market is fueled by increasing demand across industries for quality assurance and regulatory compliance. Challenges in developing precise analytical techniques provide opportunities for service providers, while government initiatives encourage investment and innovation. These factors drive market expansion globally, alongside trends such as outsourcing due to pricing concerns and the development of innovative medicines. Expansion into new locations also boosts demand for specific tests, further driving the need for healthcare analytical testing services.
"Biohealthcare analytical testing services segment accounted for a substantial share of the healthcare analytical testing services market, by type in 2023."
The Biohealthcare analytical testing services segment is expected to account for the largest share of 37.1% of the global Healthcare analytical testing services Market in 2023. It is projected to grow at the highest CAGR of 10.7% during the forecast period. The healthcare analytical testing services market is segmented by type into various categories, including bioanalytical testing, physical characterization, method development and validation, stability testing, batch-release testing, raw material testing, microbial testing, genomic services, and environmental monitoring services. In 2023, the biohealthcare analytical testing services segment stood out as the largest, primarily due to its comprehensive offerings tailored to different drug types like vaccines, small molecules, and biologics. This extensive range of services meets the diverse requirements of pharmaceutical and biopharmaceutical companies, thereby driving the segment's substantial market share.
"The cell-based assays segment accounted for the largest share in the healthcare analytical testing services market"
Based on bioanalytical service types type, the market encompasses cell-based assays, virology testing, biomarker testing, immunogenicity and neutralizing antibody testing, pharmacokinetic testing, and other biohealthcare analytical testing services. In 2023, the cell-based assays segment emerged as the market leader. This dominance is attributed to the growing preference for cell-based assays in high-throughput screening, as they offer pertinent in vivo biological insights compared to biochemical assays. This advantage accelerates the drug discovery process, thus contributing to the segment's prominence.
"North America to witness the substantial growth rate during the forecast period."
North America commands the largest share in the healthcare analytical testing services market, outstripping other regions such as Europe, Asia Pacific, Latin America, and the Middle East & Africa. This dominance is primarily fueled by the burgeoning number of biopharmaceutical and pharmaceutical companies based in the United States. Moreover, the US market benefits from the strong foothold of well-established players, which further propels the market's growth trajectory. The region's advanced infrastructure, supportive regulatory environment, and emphasis on research and development also contribute significantly to its leadership position in the global healthcare analytical testing services market.
The break-down of primary participants is as mentioned below:
- By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
- By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
- By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, ROW-10%
Key Players in the Healthcare analytical testing services Market
The prominent players in the global healthcare analytical testing services market include Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Medpace Holdings, Inc. (US), LGC Limited (Cinven) (UK), Parexel International Corporation (US), Celerion (US). Pharmaron (China), BioAgilytix Labs (US), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), Element Materials Technology (UK), Thermo Fisher Scientific, Inc. (US), Pace Analytical Services LLC (US), Intertek Group plc (UK), IQVIA Inc. (US), Merck KGaA (Germany), Source BioScience (UK), Almac Group (UK), ICON Plc (Ireland), Frontage Laboratories, Inc. (US), STERIS Plc (US), Sartorius AG (Germany), ALS Life Science (US), and Syneos Health, INC (US).
Research Coverage:
The report analyzes the Healthcare analytical testing services Market and aims to estimate the market size and future growth potential of various market segments, based on type, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
- Analysis of Market Dynamics (Stringent regulatory landscape, growing focus on analytical testing of bilogics and biomilars, rising investments in pharma and biopharma R & D), restraints (Increasing Preassure on market players due to rising cost and market competition), opportunities (Adoption of new technologies, supporting government initiatives), and challenges (increasing need for improvement of sentsitivity of bioanalytical methods)
- Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new service launches in the Healthcare analytical testing services market.
- Market Development: Comprehensive information on the lucrative emerging markets, component, demographics , end-user, and region.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare analytical testing services market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare analytical testing services market like Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), Element Materials Technology (UK) among others.
1 INTRODUCTION 50
1.1 STUDY OBJECTIVES 50
1.2 MARKET DEFINITION 50
1.2.1 INCLUSIONS & EXCLUSIONS 51
1.2.2 MARKET SEGMENTATION 52
FIGURE 1 MARKETS COVERED 52
1.2.3 REGIONS COVERED 53
FIGURE 2 REGIONAL SEGMENTATION 53
1.2.4 YEARS CONSIDERED 53
1.3 CURRENCY CONSIDERED 54
1.4 LIMITATIONS 54
1.4.1 METHODOLOGY-RELATED LIMITATIONS 54
1.4.2 SCOPE-RELATED LIMITATIONS 54
1.5 STAKEHOLDERS 54
1.6 SUMMARY OF CHANGES 55
2 RESEARCH METHODOLOGY 56
2.1 RESEARCH DATA 56
2.2 RESEARCH METHODOLOGY DESIGN 56
FIGURE 3 RESEARCH DESIGN 56
2.2.1 SECONDARY RESEARCH 57
2.2.1.1 Key data from secondary sources 58
2.2.2 PRIMARY DATA 58
FIGURE 4 PRIMARY SOURCES 59
2.2.2.1 Key data from primary sources 60
2.2.2.2 Insights from primary experts 60
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 61
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION 61
2.3 MARKET SIZE ESTIMATION METHODOLOGY 62
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 62
FIGURE 8 REVENUE SHARE ANALYSIS: COMPANY ILLUSTRATION 63
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION 63
FIGURE 10 TOP-DOWN APPROACH 64
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
FIGURE 12 CAGR PROJECTIONS 65
2.4 DATA TRIANGULATION PROCEDURE 67
FIGURE 13 DATA TRIANGULATION METHODOLOGY 67
2.5 MARKET SHARE ESTIMATION 68
2.6 STUDY ASSUMPTIONS 68
2.7 RISK ASSESSMENT 68
TABLE 1 RISK ASSESSMENT ANALYSIS 68
2.8 RECESSION IMPACT ANALYSIS 69
3 EXECUTIVE SUMMARY 70
FIGURE 14 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 70
FIGURE 15 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 71
FIGURE 16 PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 72
FIGURE 17 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 73
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 74
4 PREMIUM INSIGHTS 75
4.1 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OVERVIEW 75
FIGURE 19 GROWING ADOPTION OF OUTSOURCED ANALYTICAL TESTING SERVICES BY PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES TO DRIVE GROWTH 75
4.2 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE AND COUNTRY (2023) 76
FIGURE 20 BIOANALYTICAL TESTING SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2023 76
4.3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 77
FIGURE 21 CHINA, INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 77
4.4 REGIONAL MIX: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET (2022-2029) 78
FIGURE 22 APAC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD (2022-2029) 78
4.5 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES (2024 VS. 2029) 79
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 79
5 MARKET OVERVIEW 80
5.1 INTRODUCTION 80
5.2 MARKET DYNAMICS 80
FIGURE 24 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 80
5.2.1 DRIVERS 81
5.2.1.1 Stringent regulatory guidelines 81
5.2.1.2 Growing focus on analytical testing of biologics & biosimilars 82
TABLE 2 PATENT EXPIRY OF BEST-SELLING BIOLOGICS 82
5.2.1.3 Increasing outsourcing of analytical testing by pharmaceutical & medical device companies 82
5.2.1.4 Increasing number of clinical trials 83
FIGURE 25 INCREASING NUMBER OF CLINICAL TRIALS WORLDWIDE (2004-2024) 83
FIGURE 26 PERCENTAGE OF REGISTERED STUDIES BY LOCATION (AS OF MARCH 08, 2024) 84
5.2.1.5 Growing R&D expenditure in pharmaceutical & biopharmaceutical industry 84
FIGURE 27 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2002-2022 84
5.2.1.6 Rising acceptance of quality-by-design approach in pharmaceutical research & manufacturing 85
TABLE 3 IMPACT ANALYSIS: DRIVERS 85
5.2.2 RESTRAINTS 86
5.2.2.1 Increasing pressure on market players due to rising costs and market competition 86
TABLE 4 IMPACT ANALYSIS: RESTRAINTS 86
5.2.3 OPPORTUNITIES 87
5.2.3.1 Adoption of new techniques and technologies 87
5.2.3.2 Growing focus on emerging economies 87
TABLE 5 IMPACT ANALYSIS: OPPORTUNITIES 88
5.2.4 CHALLENGES 88
5.2.4.1 Shortage of skilled professionals 88
5.2.4.2 Specific requirements for innovative formulations and medical devices 89
5.2.4.3 Need to improve sensitivity of bioanalytical methods 89
TABLE 6 IMPACT ANALYSIS: CHALLENGES 90
5.3 ECOSYSTEM ANALYSIS 90
TABLE 7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ROLE IN ECOSYSTEM 90
FIGURE 28 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ECOSYSTEM ANALYSIS 91
5.4 VALUE CHAIN ANALYSIS 91
FIGURE 29 VALUE CHAIN ANALYSIS 91
5.5 CASE STUDY ANALYSIS 92
5.5.1 UNLOCKING BIOPHARMACEUTICAL DEVELOPMENT POTENTIAL THROUGH OUTSOURCING ANALYTICAL TESTING 92
5.5.2 REVOLUTIONIZING PHARMACEUTICAL TESTING: A CASE STUDY IN ANALYTICAL TESTING EVOLUTION 92
5.6 PORTER'S FIVE FORCES ANALYSIS 92
TABLE 8 PORTER'S FIVE FORCES ANALYSIS 92
FIGURE 30 PORTER'S FIVE FORCES ANALYSIS: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 93
5.6.1 THREAT OF NEW ENTRANTS 93
5.6.2 BARGAINING POWER OF SUPPLIERS 93
5.6.3 INTENSITY OF COMPETITIVE RIVALRY 94
5.6.4 BARGAINING POWER OF BUYERS 94
5.6.5 THREAT OF SUBSTITUTES 94
5.7 REGULATORY LANDSCAPE 95
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 13 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
5.7.2 REGULATORY ANALYSIS 96
TABLE 14 ICH QUALITY GUIDELINES FOR PHARMACEUTICAL GMPS 97
TABLE 15 OVERVIEW OF GUIDELINES OF LABORATORY SERVICES 98
5.7.3 NORTH AMERICA 98
5.7.4 EUROPE 99
TABLE 16 DEVELOPMENT OF GLP ACROSS COUNTRIES 99
TABLE 17 REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES 99
5.7.5 ASIA PACIFIC 100
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 100
FIGURE 31 REVENUE SHIFT AND NEW POCKETS: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 101
5.9 KEY CONFERENCES & EVENTS, 2024-2025 101
TABLE 18 HEALTHCARE ANALYTICAL TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS 101
5.10 INVESTMENT AND FUNDING SCENARIO 102
FIGURE 32 NUMBER OF INVESTOR DEALS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY KEY PLAYER, 2018-2022 102
FIGURE 33 VALUE OF INVESTOR DEALS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY KEY PLAYER, 2018-2022 103
5.11 KEY STAKEHOLDERS & BUYING CRITERIA 103
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 103
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 103
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 104
5.11.2 BUYING CRITERIA 104
FIGURE 35 KEY BUYING CRITERIA FOR END USERS 104
TABLE 20 KEY BUYING CRITERIA FOR END USERS 105
6 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE 106
6.1 INTRODUCTION 107
TABLE 21 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 107
6.2 BIOANALYTICAL TESTING 107
TABLE 22 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 108
TABLE 23 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 108
6.2.1 PHARMACOKINETIC & TOXICOKINETIC TESTING 109
6.2.1.1 Increasing number of clinical trials for drug development to propel growth 109
TABLE 24 PHARMACOKINETIC TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 109
6.2.2 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING 110
6.2.2.1 Increasing requirement for drug safety approvals to support market growth 110
TABLE 25 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 111
6.2.3 BIOMARKER TESTING 111
6.2.3.1 Rising need for specialized drug development to drive market 111
TABLE 26 BIOMARKER TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 112
6.2.4 BIOASSAY TESTING 112
6.2.4.1 Growing adoption of high-content screening for cytotoxicity testing to fuel growth 112
TABLE 27 BIOASSAY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 113
6.2.5 OTHER BIOANALYTICAL TESTING SERVICES 113
TABLE 28 OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 114
6.3 PHYSICAL CHARACTERIZATION 114
TABLE 29 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 115
TABLE 30 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 115
6.3.1 LASER PARTICLE SIZE ANALYSIS 116
6.3.1.1 Growing importance of particle size analysis in manufacturing pharmaceutical dosage forms to drive market 116
TABLE 31 LASER PARTICLE SIZE ANALYSIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 116
6.3.2 THERMAL ANALYSIS 117
6.3.2.1 Advancements in thermal analysis techniques to support growth 117
TABLE 32 THERMAL ANALYSIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 117
6.3.3 OPTICAL CHARACTERIZATION 117
6.3.3.1 Growing complexity of biological structures to contribute to growth 117
TABLE 33 OPTICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 118
6.3.4 SURFACE AREA ANALYSIS 118
6.3.4.1 Growing need for surface analysis to streamline drug development processes to fuel growth 118
TABLE 34 SURFACE AREA ANALYSIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 119
6.3.5 OTHER PHYSICAL CHARACTERIZATION SERVICES 119
TABLE 35 OTHER PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 120
6.4 METHOD DEVELOPMENT & VALIDATION 120
TABLE 36 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 121
TABLE 37 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 121
6.4.1 EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION 122
6.4.1.1 Growing development of parenterally administered drugs and biologic products to drive market 122
TABLE 38 EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 122
6.4.2 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION 123
6.4.2.1 Rising emphasis on impurity testing to boost market 123
TABLE 39 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 123
6.4.3 STABILITY-INDICATING METHOD VALIDATION 124
6.4.3.1 Need to ensure safety and efficacy of therapeutic drugs to spur growth 124
TABLE 40 STABILITY-INDICATING METHOD VALIDATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 124
6.4.4 CLEANING VALIDATION & METHOD DEVELOPMENT 124
6.4.4.1 Growing needs to evaluate cleaning practices and ensure complete decontamination to fuel growth 124
TABLE 41 CLEANING VALIDATION & METHOD DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 125
6.4.5 ANALYTICAL STANDARD CHARACTERIZATION 125
6.4.5.1 Growing importance of analytical standard characterization in drug development to support market 125
TABLE 42 ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 126
6.4.6 TECHNICAL CONSULTING 126
6.4.6.1 Need for regulatory approvals for drug development to drive market 126
TABLE 43 TECHNICAL CONSULTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 127
6.4.7 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES 127
TABLE 44 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 128
6.5 RAW MATERIAL TESTING 128
TABLE 45 RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 129
TABLE 46 RAW MATERIAL TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 129
6.5.1 COMPLETE COMPENDIAL TESTING 129
6.5.1.1 Need to determine efficacy and safety of therapeutic products to drive growth 129
TABLE 47 COMPLETE COMPENDIAL TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 130
6.5.2 CONTAINER TESTING 130
6.5.2.1 Need to optimize sealing and evaluate temperature impact to fuel growth 130
TABLE 48 CONTAINER TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 131
6.5.3 HEAVY METAL TESTING 131
6.5.3.1 Implementation of various techniques and technologies for heavy metal testing to aid growth 131
TABLE 49 HEAVY METAL TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 132
6.5.4 WATER CONTENT ANALYSIS 132
6.5.4.1 Need to check for water content in pharmaceutical products to support growth 132
TABLE 50 WATER CONTENT ANALYSIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 133
6.5.5 OTHER RAW MATERIAL TESTING SERVICES 133
TABLE 51 OTHER RAW MATERIAL TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 133
6.6 BATCH-RELEASE TESTING SERVICES 134
TABLE 52 BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 134
TABLE 53 BATCH-RELEASE TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 135
6.6.1 DISSOLUTION TESTING 135
6.6.1.1 Wide usage of dissolution testing in formulation development and manufacturing to drive growth 135
TABLE 54 DISSOLUTION TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 136
6.6.2 ELEMENTAL IMPURITY TESTING 136
6.6.2.1 Need to minimize cost of in-house analysis and labor to fuel growth 136
TABLE 55 ELEMENTAL IMPURITY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 137
6.6.3 DISINTEGRATION TESTING 137
6.6.3.1 Need to ensure batch-to-batch consistency of pharmaceutical dosage forms to promote growth 137
TABLE 56 BREAKDOWN OF DISINTEGRATION METHODS AND IMMERSION MEDIA 138
TABLE 57 DISINTEGRATION TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 138
6.6.4 HARDNESS TESTING 139
6.6.4.1 Need to assess manufacturability and compactness of pharmaceutical formulations to ensure growth 139
TABLE 58 HARDNESS TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 139
6.6.5 FRIABILITY TESTING 140
6.6.5.1 Need to measure resistance of tablets and granules to abrasion or fracture to support market 140
TABLE 59 FRIABILITY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 140
6.6.6 OTHER BATCH-RELEASE TESTING SERVICES 140
TABLE 60 OTHER BATCH-RELEASE TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 141
6.7 STABILITY TESTING 141
TABLE 61 STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 142
TABLE 62 STABILITY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 142
6.7.1 DRUG SUBSTANCE STABILITY TESTING 142
6.7.1.1 Regulatory requirements for drug approval to drive market 142
TABLE 63 DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 143
6.7.2 FORMULATION EVALUATION STABILITY TESTING 143
6.7.2.1 Need to analyze and predict shelf life of products to drive demand 143
TABLE 64 FORMULATION EVALUATION STABILITY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 144
6.7.3 ACCELERATED STABILITY TESTING 144
6.7.3.1 Growing use of accelerated stability testing to determine shelf life of pharmaceutical products to fuel growth 144
TABLE 65 ACCELERATED STABILITY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 145
6.7.4 PHOTOSTABILITY TESTING 145
6.7.4.1 Need for robust photostability testing process to ensure product quality and safety to drive adoption 145
TABLE 66 PHOTOSTABILITY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 146
6.7.5 FORCED DEGRADATION TESTING 146
6.7.5.1 Regulatory requirements and need for comprehensive stability testing in pharmaceutical industry to boost market 146
TABLE 67 FORCED DEGRADATION TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 147
6.7.6 OTHER STABILITY TESTING SERVICES 147
TABLE 68 OTHER STABILITY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 147
6.8 MICROBIAL TESTING 148
TABLE 69 MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 148
TABLE 70 MICROBIAL TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 149
6.8.1 MICROBIAL LIMIT TESTING 149
6.8.1.1 Need to determine whether products comply with compendial specifications for microbial quality to boost adoption 149
TABLE 71 STANDARD LIMITS FOR MICROBIAL LIMIT TESTING 150
TABLE 72 MICROBIAL LIMIT TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 150
6.8.2 VIROLOGY TESTING 150
6.8.2.1 Increasing outbreaks of viral diseases to drive market 150
TABLE 73 VIROLOGY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 151
6.8.3 STERILITY TESTING 151
6.8.3.1 Rising development of parenteral preparations and immunological products to drive market 151
TABLE 74 STERILITY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 152
6.8.4 ENDOTOXIN TESTING 152
6.8.4.1 Need to standardize procedures and follow regulatory guidelines to support demand 152
TABLE 75 ENDOTOXIN TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 153
6.8.5 PRESERVATIVE EFFICACY TESTING 153
6.8.5.1 Need to ensure product safety for product approval to support growth 153
TABLE 76 PRESERVATIVE EFFICACY TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 154
6.8.6 OTHER MICROBIAL TESTING SERVICES 154
TABLE 77 OTHER MICROBIAL TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 155
6.9 GENOMIC TESTING SERVICES 155
6.9.1 NEED TO GAIN INSIGHTS INTO DISEASE MECHANISMS AND TREATMENT RESPONSES TO BOOST MARKET 155
TABLE 78 GENOMIC TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 156
6.10 OTHER ANALYTICAL TESTING SERVICES 156
TABLE 79 OTHER ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 156
7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER 157
7.1 INTRODUCTION 158
TABLE 80 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 158
7.2 PHARMACEUTICAL COMPANIES 158
7.2.1 INCREASED OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH 158
FIGURE 36 R&D SPENDING OF PHARMA MEMBER COMPANIES, 2020-2022 159
TABLE 81 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2022-2029 (USD MILLION) 160
7.3 BIOPHARMACEUTICAL COMPANIES 160
7.3.1 GROWING INVESTMENTS IN BIOPHARMACEUTICAL COMPANIES TO BOOST MARKET GROWTH 160
TABLE 82 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022-2029 (USD MILLION) 161
7.4 MEDICAL DEVICE COMPANIES 161
7.4.1 STRICT APPROVAL NORMS FOR MEDICAL DEVICES TO SUPPORT GROWTH 161
TABLE 83 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022-2029 (USD MILLION) 162
7.5 HOSPITALS & CLINICS 162
7.5.1 GROWING PREVALENCE OF CHRONIC DISEASES TO FAVOR MARKET GROWTH 162
TABLE 84 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022-2029 (USD MILLION) 163
7.6 FORENSIC LABS 163
7.6.1 GROWING USE OF ANALYTICAL TESTING IN FORENSIC LABS TO BOOST MARKET GROWTH 163
TABLE 85 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR FORENSIC LABS, BY REGION, 2022-2029 (USD MILLION) 164
7.7 COSMETIC & NUTRACEUTICAL COMPANIES 164
7.7.1 STRINGENT GUIDELINES FOR QUALITY CONTROL TO DRIVE MARKET 164
TABLE 86 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR COSMETIC & NUTRACEUTICAL COMPANIES, BY REGION, 2022-2029 (USD MILLION) 165
8 HEALTHCARE ANALYTICAL TESTING MARKET, BY REGION 166
8.1 INTRODUCTION 167
FIGURE 37 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC SNAPSHOT 167
TABLE 87 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 168
8.2 NORTH AMERICA 168
8.2.1 NORTH AMERICA: RECESSION IMPACT 168
FIGURE 38 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 169
TABLE 88 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 170
TABLE 89 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 170
TABLE 90 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 171
TABLE 91 NORTH AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 171
TABLE 92 NORTH AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 93 NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 94 NORTH AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 173
TABLE 95 NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 173
TABLE 96 NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 97 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 174
8.2.2 US 175
8.2.2.1 High number of pre-registration drugs in pipeline to drive market 175
FIGURE 39 US: PIPELINE SPLIT OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY PHASE (JANUARY 2021) 175
TABLE 98 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 176
TABLE 99 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 176
TABLE 100 US: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 177
TABLE 101 US: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 177
TABLE 102 US: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 178
TABLE 103 US: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 178
TABLE 104 US: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 179
TABLE 105 US: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 179
8.2.3 CANADA 180
8.2.3.1 Presence of well-established CROs to support market growth 180
FIGURE 40 CANADA: ONGOING CLINICAL TRIALS, BY THERAPEUTIC AREA (2023) 180
TABLE 106 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 181
TABLE 107 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 181
TABLE 108 CANADA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 109 CANADA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 110 CANADA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 111 CANADA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 112 CANADA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 184
TABLE 113 CANADA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 184
8.3 EUROPE 185
8.3.1 EUROPE: RECESSION IMPACT 185
TABLE 114 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 186
TABLE 115 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 186
TABLE 116 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 187
TABLE 117 EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 187
TABLE 118 EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 188
TABLE 119 EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 188
TABLE 120 EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 121 EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 122 EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 190
TABLE 123 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 190
8.3.2 GERMANY 191
8.3.2.1 Government support and flexible labor laws make Germany favorable location for clinical trials 191
TABLE 124 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 192
TABLE 125 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 192
TABLE 126 GERMANY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 127 GERMANY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 128 GERMANY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 129 GERMANY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 130 GERMANY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 131 GERMANY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 195
8.3.3 FRANCE 196
8.3.3.1 Favorable government regulations to drive market 196
TABLE 132 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 197
TABLE 133 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 197
TABLE 134 FRANCE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 135 FRANCE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 136 FRANCE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 199
TABLE 137 FRANCE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 199
TABLE 138 FRANCE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 200
TABLE 139 FRANCE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 200
8.3.4 UK 201
8.3.4.1 Investments by pharmaceutical sponsors for drug discovery services to support growth 201
TABLE 140 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 141 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 142 UK: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 143 UK: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 203
TABLE 144 UK: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 203
TABLE 145 UK: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 146 UK: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 147 UK: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 205
8.3.5 ITALY 205
8.3.5.1 Low drug approval time to support market growth 205
TABLE 148 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 149 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 150 ITALY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 151 ITALY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 152 ITALY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 208
TABLE 153 ITALY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 208
TABLE 154 ITALY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 155 ITALY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 209
8.3.6 SWITZERLAND 210
8.3.6.1 Large and growing pharma production volume to drive demand for analytical testing services 210
TABLE 156 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 210
TABLE 157 SWITZERLAND: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 211
TABLE 158 SWITZERLAND: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 211
TABLE 159 SWITZERLAND: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 160 SWITZERLAND: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 161 SWITZERLAND: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 162 SWITZERLAND: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 163 SWITZERLAND: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 214
8.3.7 SPAIN 214
8.3.7.1 Rising R&D expenditure to boost growth 214
TABLE 164 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 215
TABLE 165 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 215
TABLE 166 SPAIN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 167 SPAIN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 168 SPAIN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 169 SPAIN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 170 SPAIN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 171 SPAIN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 218
8.3.8 REST OF EUROPE 219
TABLE 172 REST OF EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 220
TABLE 173 REST OF EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 220
TABLE 174 REST OF EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 221
TABLE 175 REST OF EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 221
TABLE 176 REST OF EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 177 REST OF EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 178 REST OF EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 179 REST OF EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 223
8.4 ASIA PACIFIC 224
8.4.1 ASIA PACIFIC: RECESSION IMPACT 224
FIGURE 41 ASIA PACIFIC: HEALTHCARE ANALYTICS TESTING SERVICES MARKET SNAPSHOT 225
TABLE 180 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 226
TABLE 181 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 226
TABLE 182 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 227
TABLE 183 ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 227
TABLE 184 ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 185 ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 186 ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 229
TABLE 187 ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 229
TABLE 188 ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 230
TABLE 189 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 230
8.4.2 CHINA 231
8.4.2.1 Low manufacturing cost of medicines to drive demand 231
TABLE 190 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 232
TABLE 191 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 232
TABLE 192 CHINA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 233
TABLE 193 CHINA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 233
TABLE 194 CHINA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 195 CHINA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 196 CHINA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 235
TABLE 197 CHINA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 235
8.4.3 JAPAN 235
8.4.3.1 Rising geriatric population to support market growth 235
TABLE 198 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 236
TABLE 199 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 237
TABLE 200 JAPAN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 237
TABLE 201 JAPAN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 238
TABLE 202 JAPAN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 238
TABLE 203 JAPAN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 239
TABLE 204 JAPAN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 239
TABLE 205 JAPAN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 240
8.4.4 INDIA 240
8.4.4.1 Increasing number of clinical trials to drive market 240
TABLE 206 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 241
TABLE 207 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 241
TABLE 208 INDIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 242
TABLE 209 INDIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 242
TABLE 210 INDIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 243
TABLE 211 INDIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 243
TABLE 212 INDIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 244
TABLE 213 INDIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 244
8.4.5 AUSTRALIA 245
8.4.5.1 Large number of research institutes make Australia favorable location for drug discovery 245
TABLE 214 AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 245
TABLE 215 AUSTRALIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 216 AUSTRALIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 217 AUSTRALIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 247
TABLE 218 AUSTRALIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 247
TABLE 219 AUSTRALIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 248
TABLE 220 AUSTRALIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 248
TABLE 221 AUSTRALIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 249
8.4.6 SOUTH KOREA 249
8.4.6.1 Growth in clinical trial activities to propel market 249
TABLE 222 SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 250
TABLE 223 SOUTH KOREA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 251
TABLE 224 SOUTH KOREA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 251
TABLE 225 SOUTH KOREA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 252
TABLE 226 SOUTH KOREA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 252
TABLE 227 SOUTH KOREA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 253
TABLE 228 SOUTH KOREA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 253
TABLE 229 SOUTH KOREA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 254
8.4.7 REST OF ASIA PACIFIC 254
TABLE 230 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 255
TABLE 231 REST OF ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 255
TABLE 232 REST OF ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 256
TABLE 233 REST OF ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 256
TABLE 234 REST OF ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 257
TABLE 235 REST OF ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 257
TABLE 236 REST OF ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 258
TABLE 237 REST OF ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 258
8.5 LATIN AMERICA 259
8.5.1 LATIN AMERICA: RECESSION IMPACT 259
TABLE 238 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 260
TABLE 239 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 260
TABLE 240 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 261
TABLE 241 LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 261
TABLE 242 LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 262
TABLE 243 LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 262
TABLE 244 LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 263
TABLE 245 LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 263
TABLE 246 LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 264
TABLE 247 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 264
8.5.2 BRAZIL 265
8.5.2.1 Rising adoption of emerging medical technologies to drive market 265
TABLE 248 BRAZIL: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 266
TABLE 249 BRAZIL: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 266
TABLE 250 BRAZIL: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 267
TABLE 251 BRAZIL: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 267
TABLE 252 BRAZIL: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 268
TABLE 253 BRAZIL: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 268
TABLE 254 BRAZIL: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 269
TABLE 255 BRAZIL: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 269
8.5.3 MEXICO 270
8.5.3.1 Government initiatives and robust supply to drive market 270
TABLE 256 MEXICO: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 271
TABLE 257 MEXICO: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 271
TABLE 258 MEXICO: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 272
TABLE 259 MEXICO: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 272
TABLE 260 MEXICO: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 273
TABLE 261 MEXICO: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 273
TABLE 262 MEXICO: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 274
TABLE 263 MEXICO: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 274
8.5.4 REST OF LATIN AMERICA 275
TABLE 264 REST OF LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 275
TABLE 265 REST OF LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 276
TABLE 266 REST OF LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 276
TABLE 267 REST OF LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 277
TABLE 268 REST OF LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 277
TABLE 269 REST OF LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 278
TABLE 270 REST OF LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 278
TABLE 271 REST OF LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 279
8.6 MIDDLE EAST & AFRICA 279
8.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 280
TABLE 272 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 280
TABLE 273 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 281
TABLE 274 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 281
TABLE 275 MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 282
TABLE 276 MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 282
TABLE 277 MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 283
TABLE 278 MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 283
TABLE 279 MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 284
TABLE 280 MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 284
TABLE 281 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 285
8.6.2 GCC 285
8.6.2.1 Supportive government initiatives to aid market growth 285
TABLE 282 GCC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 286
TABLE 283 GCC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 286
TABLE 284 GCC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 287
TABLE 285 GCC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 287
TABLE 286 GCC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 288
TABLE 287 GCC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 288
TABLE 288 GCC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 289
TABLE 289 GCC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 289
8.6.3 REST OF MIDDLE EAST & AFRICA 290
TABLE 290 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 290
TABLE 291 REST OF MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 291
TABLE 292 REST OF MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 291
TABLE 293 REST OF MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 292
TABLE 294 REST OF MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 292
TABLE 295 REST OF MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 293
TABLE 296 REST OF MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 293
TABLE 297 REST OF MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 294
9 COMPETITIVE LANDSCAPE 295
9.1 INTRODUCTION 295
9.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 296
FIGURE 42 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: STRATEGIES ADOPTED 296
9.3 REVENUE SHARE ANALYSIS 297
FIGURE 43 REVENUE ANALYSIS FOR KEY PLAYERS (2018-2022) 297
9.4 MARKET SHARE ANALYSIS 298
FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) 298
TABLE 298 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEGREE OF COMPETITION 298
9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 299
9.5.1 STARS 300
9.5.2 PERVASIVE PLAYERS 300
9.5.3 EMERGING LEADERS 300
9.5.4 PARTICIPANTS 300
FIGURE 45 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 301
9.5.5 COMPANY FOOTPRINT 302
9.5.5.1 Overall footprint 302
FIGURE 46 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: OVERALL FOOTPRINT 302
9.5.5.2 Service footprint 303
TABLE 299 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: SERVICE FOOTPRINT 303
9.5.5.3 End-user footprint 304
TABLE 300 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: END-USER FOOTPRINT 304
9.5.5.4 Regional footprint 305
TABLE 301 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: REGIONAL FOOTPRINT 305
9.6 COMPANY EVALUATION MATRIX: START-UPS/SMES 306
9.6.1 PROGRESSIVE COMPANIES 306
9.6.2 DYNAMIC COMPANIES 306
9.6.3 RESPONSIVE COMPANIES 306
9.6.4 STARTING BLOCKS 306
FIGURE 47 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023 307
9.6.5 COMPETITIVE BENCHMARKING 308
TABLE 302 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DETAILED LIST OF KEY START-UPS/SMES 308
TABLE 303 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 309
9.7 VALUATION AND FINANCIAL METRICS OF HEALTHCARE ANALYTICAL TESTING SERVICE VENDORS 310
FIGURE 48 EV/EBITDA OF KEY VENDORS 310
9.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 311
FIGURE 49 BRAND/PRODUCT COMPARATIVE ANALYSIS OF KEY PLAYERS, BY SERVICE TYPE 311
9.8.1 EUROFINS SCIENTIFIC 312
9.8.2 WUXI APPTEC 312
9.8.3 CHARLES RIVER LABORATORIES 312
9.8.4 SGS S.A. 312
9.8.5 LABORATORY CORPORATION OF AMERICA HOLDINGS 313
9.9 COMPETITIVE SCENARIO 313
9.9.1 SERVICE LAUNCHES 313
TABLE 304 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: SERVICE LAUNCHES, JANUARY 2020-MARCH 2024 313
9.9.2 DEALS 314
TABLE 305 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEALS, JANUARY 2020-MARCH 2024 314
TABLE 306 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: EXPANSIONS, JANUARY 2020-MARCH 2024 315
?
10 COMPANY PROFILES 318
10.1 KEY PLAYERS 318
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
10.1.1 EUROFINS SCIENTIFIC 318
TABLE 307 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 318
FIGURE 50 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022) 319
TABLE 308 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 319
TABLE 309 EUROFINS SCIENTIFIC: DEALS 321
10.1.2 LABORATORY CORPORATION OF AMERICA HOLDINGS 323
TABLE 310 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW 323
FIGURE 51 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2022) 324
TABLE 311 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 324
TABLE 312 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS 325
TABLE 313 LABORATORY CORPORATION OF AMERICA HOLDINGS: EXPANSIONS 326
10.1.3 WUXI APPTEC 327
TABLE 314 WUXI APPTEC: COMPANY OVERVIEW 327
FIGURE 52 WUXI APPTEC: COMPANY SNAPSHOT (2022) 328
TABLE 315 WUXI APPTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 328
TABLE 316 WUXI APPTEC: SERVICE LAUNCHES 329
TABLE 317 WUXI APPTEC: DEALS 330
TABLE 318 WUXI APPTEC: EXPANSIONS 330
10.1.4 CHARLES RIVER LABORATORIES 332
TABLE 319 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 332
FIGURE 53 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022) 333
TABLE 320 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 333
TABLE 321 CHARLES RIVER LABORATORIES: SERVICE LAUNCHES 334
TABLE 322 CHARLES RIVER LABORATORIES: DEALS 335
10.1.5 SGS S.A. 338
TABLE 323 SGS S.A.: COMPANY OVERVIEW 338
FIGURE 54 SGS S.A.: COMPANY SNAPSHOT (2023) 339
TABLE 324 SGS S.A.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 339
TABLE 325 SGS S.A.: DEALS 341
TABLE 326 SGS S.A.: OTHER DEVELOPMENTS 342
10.1.6 THERMO FISHER SCIENTIFIC INC. 344
TABLE 327 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 344
FIGURE 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 345
TABLE 328 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 345
TABLE 329 THERMO FISHER SCIENTIFIC INC.: DEALS 346
TABLE 330 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS 347
10.1.7 MEDPACE, INC. 348
TABLE 331 MEDPACE, INC.: COMPANY OVERVIEW 348
FIGURE 56 MEDPACE, INC.: COMPANY SNAPSHOT (2022) 348
TABLE 332 MEDPACE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 349
10.1.8 SARTORIUS AG 350
TABLE 333 SARTORIUS AG: COMPANY OVERVIEW 350
FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT (2022) 351
TABLE 334 SARTORIUS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 351
TABLE 335 SARTORIUS AG: DEALS 352
10.1.9 INTERTEK GROUP PLC 353
TABLE 336 INTERTEK GROUP PLC: COMPANY OVERVIEW 353
FIGURE 58 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2022) 354
TABLE 337 INTERTEK GROUP PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 354
TABLE 338 INTERTEK GROUP PLC: DEALS 357
TABLE 339 INTERTEK GROUP PLC: EXPANSIONS 357
10.1.10 MERCK KGAA 358
TABLE 340 MERCK KGAA: COMPANY OVERVIEW 358
FIGURE 59 MERCK KGAA: COMPANY SNAPSHOT (2022) 359
TABLE 341 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 359
TABLE 342 MERCK KGAA: SERVICE LAUNCHES 360
TABLE 343 MERCK KGAA: DEALS 360
TABLE 344 MERCK KGAA: EXPANSIONS 361
TABLE 345 MERCK KGAA: OTHER DEVELOPMENTS 361
10.1.11 SOURCE BIOSCIENCE 363
TABLE 346 SOURCE BIOSCIENCE: COMPANY OVERVIEW 363
FIGURE 60 SOURCE BIOSCIENCE: COMPANY SNAPSHOT (2022) 364
TABLE 347 SOURCE BIOSCIENCE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 364
TABLE 348 SOURCE BIOSCIENCE: SERVICE LAUNCHES 365
TABLE 349 SOURCE BIOSCIENCE: EXPANSIONS 365
10.1.12 ICON PLC 366
TABLE 350 ICON PLC: COMPANY OVERVIEW 366
FIGURE 61 ICON PLC: COMPANY SNAPSHOT (2022) 366
TABLE 351 ICON PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 367
TABLE 352 ICON PLC: DEALS 368
10.1.13 ALS 369
TABLE 353 ALS: COMPANY OVERVIEW 369
FIGURE 62 ALS: COMPANY SNAPSHOT (2022) 370
TABLE 354 ALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 370
TABLE 355 ALS: DEALS 371
10.1.14 FRONTAGE LABORATORIES, INC. 372
TABLE 356 FRONTAGE LABORATORIES, INC.: COMPANY OVERVIEW 372
FIGURE 63 FRONTAGE LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 373
TABLE 357 FRONTAGE LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 373
TABLE 358 FRONTAGE LABORATORIES, INC.: DEALS 375
TABLE 359 FRONTAGE LABORATORIES, INC.: OTHER DEVELOPMENTS 376
10.1.15 STERIS 377
TABLE 360 STERIS: COMPANY OVERVIEW 377
FIGURE 64 STERIS: COMPANY SNAPSHOT (2023) 378
TABLE 361 STERIS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 378
10.1.16 IQVIA INC. 380
TABLE 362 IQVIA INC.: COMPANY OVERVIEW 380
FIGURE 65 IQVIA INC.: COMPANY SNAPSHOT (2023) 381
TABLE 363 IQVIA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 381
TABLE 364 IQVIA INC.: OTHER DEVELOPMENTS 382
10.1.17 ELEMENT MATERIALS TECHNOLOGY 383
TABLE 365 ELEMENT MATERIALS TECHNOLOGY: COMPANY OVERVIEW 383
TABLE 366 ELEMENT MATERIALS TECHNOLOGY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 383
TABLE 367 ELEMENT MATERIALS TECHNOLOGY: SERVICE LAUNCHES 384
TABLE 368 ELEMENT MATERIALS TECHNOLOGY: DEALS 384
TABLE 369 ELEMENT MATERIALS TECHNOLOGY: EXPANSIONS 385
10.1.18 PACE ANALYTICAL SERVICES 386
TABLE 370 PACE ANALYTICAL SERVICES: COMPANY OVERVIEW 386
TABLE 371 PACE ANALYTICAL SERVICES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 386
TABLE 372 PACE ANALYTICAL SERVICES: DEALS 388
TABLE 373 PACE ANALYTICAL SERVICES: OTHER DEVELOPMENTS 390
10.1.19 ALMAC GROUP 391
TABLE 374 ALMAC GROUP: COMPANY OVERVIEW 391
TABLE 375 ALMAC GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 391
TABLE 376 ALMAC GROUP: SERVICE LAUNCHES 392
TABLE 377 ALMAC GROUP: EXPANSIONS 392
10.1.20 PHARMARON 393
TABLE 378 PHARMARON: COMPANY OVERVIEW 393
TABLE 379 PHARMARON: PRODUCTS/SERVICES/SOLUTIONS OFFERED 393
TABLE 380 PHARMARON: DEALS 394
10.2 OTHER PLAYERS 395
10.2.1 SYNEOS HEALTH 395
TABLE 381 SYNEOS HEALTH: COMPANY OVERVIEW 395
10.2.2 PAREXEL INTERNATIONAL (MA) CORPORATION 396
TABLE 382 PAREXEL INTERNATIONAL (MA) CORPORATION: COMPANY OVERVIEW 396
10.2.3 LGC LIMITED 397
TABLE 383 LGC LIMITED: COMPANY OVERVIEW 397
10.2.4 CELERION 398
TABLE 384 CELERION: COMPANY OVERVIEW 398
10.2.5 BIOAGILYTIX 399
TABLE 385 BIOAGILYTIX: COMPANY OVERVIEW 399
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
11 APPENDIX 400
11.1 DISCUSSION GUIDE 400
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 405
11.3 CUSTOMIZATION OPTIONS 407
11.4 RELATED REPORTS 407
11.5 AUTHOR DETAILS 408
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security